MD
Associate Director of Cellular Therapy
Stem cell transplant is an incredible field that allows me to practice the best of modern medicine, continue to understand the elegant workings of the human body and allow me to do this with utmost care and compassion for the highest and most vulnerable population of patients.
University of Santo Tomas, Manila, Philippines
Internal Medicine – Rush University Medical Center, Chicago, Illinois
Hematology/Oncology – Loyola University Medical Center, Maywood, Illinois
Hematology/Oncology – American Board of Internal Medicine
Aileen Go, MD, is the associate director of cellular therapy at City of Hope® Cancer Center Phoenix, where she provides patients with access to state-of-the-art treatment options, including stem cell transplantation, CAR T cell therapy and a range of other leading-edge cellular therapies. An expert in her field, Dr. Go focuses on treating patients with hematologic malignancies such as acute leukemia and bone marrow disorders, often using molecular profiling to provide personalized care.
“I am thankful to be part of one of the largest and best bone marrow and stem cell transplant programs in the United States, and to collaborate with thought leaders and academics in order to bring leading-edge, personalized care to patients with hematologic malignancies in Arizona,” says Dr. Go.
Dedicated to City of Hope’s mission to expand cancer care to patients throughout the United States, Dr. Go also works closely with other researchers and physicians to offer patients access to clinical trials designed to improve outcomes and reduce side effects related to stem cell transplantation and certain cellular therapies.
Dr. Go earned her medical degree at the University of Santo Tomas in the Philippines, where she grew up. She then moved to the United States and completed an internal medicine residency at Rush University Medical Center in Chicago, where she found a passion for malignant hematology and stem cell transplantation, focusing her research efforts on improving engraftment kinetics and the association of comorbidity scoring in post-transplant outcomes.
During her fellowship in hematology/oncology at Loyola University Medical Center in Maywood, Illinois, Dr. Go worked closely with one of the pioneers of stem cell transplantation, Dr. Patrick J. Stiff, and helped improve outcomes for elderly patients with acute myeloid leukemia, who have higher risk and poorer outcomes due to issues like comorbidities and donor availability.
Prior to joining City of Hope, Dr. Go helped build two successful stem cell and cellular therapy programs in the Phoenix area, serving patients with a variety of bone marrow and blood disorders. At City of Hope, she’s continued to conduct leading-edge research and bring new treatment options into the clinic.
“I continue to focus on improving patient outcomes by refining our high-dose chemoradiotherapy regimens to allow for less treatment toxicity and better infectious disease prevention for the most immunocompromised of patients,” she says. “I also continue to search for ways to lessen disease-specific mortality, especially for patients with the highest risk of relapse.”
A board-certified hematologist-oncologist, Dr. Go has held both clinical and research positions at multiple institutions and is a member of the American Society for Transplantation and Cellular Therapy and the American Society of Hematology. In her free time, she enjoys spending time with her husband and their two dogs, traveling and attending sporting events and concerts.